Inhibition of an organophosphate-detoxifying bacterial phosphotriesterase by albumin and plasma thiol components.

• The phosphotriesterase from Brevundimonas diminuta can hydrolyse OP nerve agents. • BdPTE has shown less efficient breakdown of an OP in an animal model than in vitro. • We have performed inhibition studies with plasma components using PXE as substrate. • We demonstrate that BdPTE is inhibited by serum albumin via depletion of zinc ions. • Zinc ions are crucial for the active site and are a critical component of enzyme formulation. The phosphotriesterase of the bacterium Brevundimonas diminuta (BdPTE) is a naturally occurring enzyme that catalyzes the hydrolysis of organophosphate (OP) nerve agents as well as pesticides and offers a potential treatment of corresponding intoxications. While BdPTE mutants with improved catalytic efficiencies against several OPs have been described, unexpectedly, less efficient breakdown of an OP was observed upon application in an animal model compared with in vitro measurements. Here, we describe detailed inhibition studies with the high-activity BdPTE mutant 10-2C3(C59M/C227A) by human plasma components, indicating that this enzyme is inhibited by serum albumin. The inhibitory activity is mediated by depletion of crucial zinc ions from the BdPTE active site, either via the known high-affinity zinc binding site of albumin or via chemical complex formation with its free thiol side chain at position Cys34. Albumin pre-charged with zinc ions or carrying a chemically blocked Cys34 side chain showed significantly reduced inhibitory activity; in fact, the combination of both measures completely abolished BdPTE inhibition. Consequently, the available zinc ion concentration in blood plays an important role for BdPTE activity in vivo and should be taken into account for therapeutic development and application of a catalytic OP scavenger. [ABSTRACT FROM AUTHOR]